Invalidation in patient with fibromyalgia. Fibromyalgia
Conditions
Interventions
Intervention 1: Intervention group: Group one includes patients diagnosed with fibromyalgia receiving duloxetine with the initial dose of 30 mg daily in form of oral capsule for one month. The dose wi
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Female . Patients must meet the American College of Rheumatology criteria for fibromyalgia (ACR2010). A rheumatologist confirm diagnosis of fibromyalgia.
Exclusion criteria
Exclusion criteria: Age younger than 18 or older than 65 years old Pregnancy . Taking MAOIs (monoamine oxidase inhibitors) in the 14 days before study. Cases of chronic liver disease, severe renal failure and uncontrolled narrow angle glaucoma. History of sensitivity to Pregabalin and its components. History of sensitivity to Duloxetine and its components.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Invalidation in patient with fibromyalgia. Timepoint: Before starting the study, then one month after taking medication. Method of measurement: Illness invalidation questionnaire.;Depression score in Beck depression inventory. Timepoint: Before starting the study,then one month after taking medication. Method of measurement: Beck depression questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of disease. Timepoint: Before starting the study, then one month after taking medication. Method of measurement: FIQR Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBanafshe Ghavidel parsa
Rasht University of Medical Sciences
Outcome results
None listed